Startups channel feed – Endpoints News

Startups channel feed

Boehringer Ingelheim VC backs plan to send GMO bacteria after tumors

6 years ago

An oncology upstart with some deep-pocket VC connections has a unicorn-sized venture round to back the pipeline

6 years ago

Mushroom magic draws $80M injection for London-based mental health startup

6 years ago

Nimbus founder Rosana Kapeller has a new company, with $50M and an eye on the ‘repeatome’

6 years ago

It's not developing drugs that bind to RNA, or morphing RNA into a therapeutic — this Cambridge startup has scored $63M to work on RNA-modifying proteins

6 years ago

Big Pharma VC firms put $11M in seed funds behind cancer startup with bold vision

6 years ago

A longtime Laura Shawver fan calls the serial entrepreneur back to the helm of a biotech upstart

6 years ago

Lantern Pharma charts course for IPO with AI platform that shines light on failed cancer drugs

6 years ago

Abundant funding, sparse data: San Francisco startup backs 'real world' model for rare disease drug development

6 years ago

The newest, $86M Third Rock startup chases the tiny biological machines inside of you

6 years ago

Weathering the storm: Another biotech braves Covid-19 in upsized IPO

6 years ago

Another protein degradation biotech emerges, with the promise of a new approach from an old hand

6 years ago

A quiver of arrows for immune disorders: Pandion scores $80M in fresh funding

6 years ago

David Hallal bags another whopper round, looking to recruit more cell and gene therapy upstarts to ElevateBio BaseCamp

6 years ago

Coupling mRNA with tRNA and new delivery tech, MPM and OrbiMed help birth new $80M biotech into a slowed down world

6 years ago

Turn on, tune in: New York biotech scores $15M+ in chemogenetics bet

6 years ago

A key player behind 2 multibillion-dollar biotech M&A deals is back in the startup business

6 years ago

Former Shire execs set up shop to take a shot at 'under the radar' cancer target

6 years ago

Silverback Therapeutics gets $78M boost to 'reconceptualize' antibody-drug conjugates

6 years ago

Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital

6 years ago

Ex nihilo: Takeda leads $100M+ round to fund biotech's sneak attack on tumors, propelling new IL-2, CTLA-4 drugs to clinic

6 years ago

Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO

6 years ago

SoftBank's newest, $165M biotech investment looks for infectious traces in the blood

6 years ago

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

6 years ago

First page Previous page 53 54 555657 58 59 Next page Last page